Home Applications 206111 Application 206111
Type NDA
Sponsor BOEHRINGER INGELHEIM Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET;ORAL 5MG;500MG Yes No 002 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET;ORAL 5MG;1GM Yes No 003 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET;ORAL 12.5MG;500MG Yes No 004 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET;ORAL 12.5MG;1GM Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N206111-001 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE 5MG;500MG TABLET / ORAL RLD 2015-08-26 N206111-002 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE 5MG;1GM TABLET / ORAL RLD 2015-08-26 N206111-003 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 N206111-004 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26
Orange Book patents# Current patent rows page 1 of 2 · 120 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 8 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 d06236e962d9…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 46 · 1,816 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N206111-001 7713938 2027-04-15 Drug substance, Drug product 2015-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 7713938*PED 2027-10-15 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 7579449 2028-08-01 Drug substance 2015-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 7579449*PED 2029-02-01 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 12115179 2030-02-11 U-4023 2024-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 12115179*PED 2030-08-11 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 10610489 2030-09-30 Drug product 2020-05-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 10610489*PED 2031-03-30 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 10258637 2034-04-03 U-2290 2019-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 11090323 2034-04-03 U-3193 2021-08-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 11666590 2034-04-03 U-4154 2025-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 11813275 2034-04-03 U-3759 2023-12-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 11833166 2034-04-03 U-3776 2024-01-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 11833166 2034-04-03 U-3777 2024-01-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 12263153 2034-04-03 U-4154 2025-04-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 12427162 2034-04-03 U-4287 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 12433906 2034-04-03 U-4304 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 12433906 2034-04-03 U-4293 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 12433906 2034-04-03 U-4294 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 12433906 2034-04-03 U-4295 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 12433906 2034-04-03 U-4296 2025-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 9949997 2034-05-17 U-3532 2023-03-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 9949997 2034-05-17 U-3533 2023-03-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 10258637*PED 2034-10-03 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 11090323*PED 2034-10-03 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 11813275*PED 2034-10-03 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 11833166*PED 2034-10-03 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 12433906*PED 2034-10-03 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-001 9949997*PED 2034-11-17 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-002 7713938 2027-04-15 Drug substance, Drug product 2015-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-002 7713938*PED 2027-10-15 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-002 7579449 2028-08-01 Drug substance 2015-09-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-002 7579449*PED 2029-02-01 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-002 12115179 2030-02-11 U-4023 2024-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-002 12115179*PED 2030-08-11 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-002 10610489 2030-09-30 Drug product 2020-05-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-002 10610489*PED 2031-03-30 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-002 10258637 2034-04-03 U-2290 2019-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-002 11090323 2034-04-03 U-3193 2021-08-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-002 11666590 2034-04-03 U-4154 2025-03-28 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 6 · 208 observed states.
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 20 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0597-0159 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0159 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0159 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0159 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0159 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0168 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0168 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0168 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0168 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0168 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0175 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0175 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0175 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0175 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0175 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0180 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0180 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0180 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0180 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0180 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current